Forensic Aspect of Association of Low-density Lipoprotein and Retinopathy in Diabetic Patients
DOI:
https://doi.org/10.37506/ijfmt.v17i4.19963Keywords:
Diabetic patients, Diabetic retinopathy, Low-density lipoprotein, Forensic retinopathy, etc.Abstract
Introduction: Around 10% of people with diabetes are at risk of losing their eyesight due to diabetic retinopathy,
which is a leading cause of blindness globally. Numerous studies have shown that limiting the incidence and
progression of diabetic retinopathy requires thorough treatment of the risk factors for the disease in situations
involving diabetic patients who have had retinopathy, forensic specialists are frequently requested to review
medical data and offer expert testimony. In such circumstances, physicians may investigate the patient’s medical
history, taking into account their LDL levels and other risk factors, to see if medical malpractice or carelessness
contributed to the development of retinopathy.
Aims: The objective is to develop medical provider guidelines, estimate the prospective association between lowdensity
lipoprotein (LDL) and the risk of retinopathy in diabetic patients with type 2 diabetes, and look into any
possible role for malpractice or negligence on the part of medical professionals.
Methods: This was a cross-sectional analysis of all 300 samples collected from patients diagnosed with diabetic
retinopathy at the Dr. Ram Manohar Lohia Institute of Medical Sciences Lucknow. Using univariate, bivariate, and
multivariate analyses, retinal results were associated with blood lipid levels.
Result: In diabetic patients with retinopathy, LDL values were considerably greater than in those without
retinopathy (p 0.001). Studying the forensic aspects of the relationship between LDL and diabetic patients’
retinopathy is crucial because it can enhance patient outcomes and guard against malpractice and mistakes in
medicine.
Conclusion: Low-density lipoprotein cholesterol is a sensitive target marker to foretell cardiovascular events as
well as the requirement for laser therapy in individuals with hypercholesterolemia and diabetic retinopathy. The
judicial system’s capacity to establish responsibility and pay damages in such situations may be affected by the use
of LDL levels as a biomarker for predicting the development of retinopathy.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en